# Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer

> **NCT00301860** · NA · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 8 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** therapeutic allogeneic lymphocytes
- **DRUG:** cyclosporine
- **DRUG:** fludarabine phosphate
- **DRUG:** melphalan
- **DRUG:** methotrexate
- **PROCEDURE:** allogeneic hematopoietic stem cell transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00301860
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2007-03
- **Final completion:** 2007-11
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** lack of efficacy
- **Last updated:** 2013-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301860, "Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00301860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*